Clinical Trials Browser

Completed × Paraproteinemias × Alemtuzumab × Clear all

NCT00048412 2020-01-18

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Phase 1/2 Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoproliferative Disorders, Multiple Myeloma, Paraproteinemias